Literature DB >> 34261630

Glioblastoma: clinical presentation, diagnosis, and management.

Chris McKinnon1, Meera Nandhabalan2, Scott A Murray3, Puneet Plaha4.   

Abstract

Entities:  

Year:  2021        PMID： 34261630     DOI： 10.1136/bmj.n1560

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

1.  An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16.

Authors:  Liya Ma; Gen Li; Tianquan Yang; Li Zhang; Xinxin Wang; Xiaowen Xu; Hong Ni
Journal:  Cancer Chemother Pharmacol       Date:  2022-10-12       Impact factor: 3.288

2.  ZNF395 facilitates macrophage polarization and impacts the prognosis of glioma.

Authors:  Feng Xiao; Jie Shen; Lihui Zhou; Zebin Fang; Yuxiang Weng; Chao Zhang; Luyuan Zhang; Xin Huang; Renya Zhan
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 3.  The Use of 18F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds-A Narrative Review.

Authors:  Tineke van de Weijer; Martijn P G Broen; Rik P M Moonen; Ann Hoeben; Monique Anten; Koos Hovinga; Inge Compter; Jochem A J van der Pol; Cristina Mitea; Toine M Lodewick; Arnaud Jacquerie; Felix M Mottaghy; Joachim E Wildberger; Alida A Postma
Journal:  Diagnostics (Basel)       Date:  2022-05-11

4.  Early Unplanned Reoperation After Glioma Craniotomy: Incidence, Predictor and Process Improvement.

Authors:  Yu Zhang; Peigang Ji; Shoujie Wang; Huaizhou Qin; Qing Cai
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

5.  Construction of a novel radiosensitivity- and ferroptosis-associated gene signature for prognosis prediction in gliomas.

Authors:  Yandong Xie; Yong Xiao; Yuyang Liu; Xueying Lu; Zhen Wang; Shuo Sun; Liang Liu; Xianglong Tang; Hong Xiao; Hongyi Liu
Journal:  J Cancer       Date:  2022-05-20       Impact factor: 4.478

6.  Sulforaphane Causes Cell Cycle Arrest and Apoptosis in Human Glioblastoma U87MG and U373MG Cell Lines under Hypoxic Conditions.

Authors:  Giulia Sita; Agnese Graziosi; Patrizia Hrelia; Fabiana Morroni
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

7.  LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1.

Authors:  Jingshan Liang; Changtao Liu; Dezhi Xu; Kang Xie; Aimin Li
Journal:  J Transl Med       Date:  2022-02-05       Impact factor: 5.531

8.  Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas.

Authors:  Jingwei Zhang; Zeyu Wang; Hao Zhang; Ziyu Dai; Xisong Liang; Shuwang Li; Xun Zhang; Fangkun Liu; Zhixiong Liu; Kui Yang; Quan Cheng
Journal:  Front Cell Dev Biol       Date:  2022-02-09

9.  NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun.

Authors:  Zigui Chen; Yingying Xie; Hongcheng Luo; Ye Song; Tianshi Que; Rentong Hu; Huatuo Huang; Kunxiang Luo; Chuanyu Li; Chengjian Qin; Chuanhua Zheng; Weiyi Fang; Longyang Liu; Hao Long; Qisheng Luo
Journal:  Aging (Albany NY)       Date:  2021-12-27       Impact factor: 5.682

10.  Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.

Authors:  Zijian Zhou; JinHong Wei; Zeruo Yang; Yue Bao; Wenbo Jiang; Bin Lu; Weimin Wang; Luo Li
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.